Relocalization of junctional adhesion molecule a during inflammatory stimulation of brain endothelial cells

Molecular and Cellular Biology

Volumn 32, Issue 17, 2012, Pages 3414-3427

  Stamatovic, Svetlana M ^a   Sladojevic, Nikola ^a   Keep, Richard F ^a   Andjelkovic, Anuska V ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 (N ETHYL N ISOPROPYL)AMILORIDE; CXCL2 CHEMOKINE; DEXTRAN; JUNCTIONAL ADHESION MOLECULE A; RHO KINASE; SMALL INTERFERING RNA;

ANIMAL CELL; APICAL MEMBRANE; ARTICLE; BRAIN CELL; CELL MIGRATION; CELL STIMULATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENDOTHELIUM CELL; INFLAMMATION; MONOCYTE; MOUSE; NEUTROPHIL; NONHUMAN; PINOCYTOSIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; BRAIN; CELL ADHESION MOLECULES; CELL LINE; CELLS, CULTURED; CHEMOKINE CCL2; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; MICE; MICE, INBRED C57BL; PROTEIN TRANSPORT; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION; TIGHT JUNCTIONS;

EID: 84866292915     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.06678-11     Document Type: Article

References (61)

1. Abbott NJ. 2000. Inflammatory mediators and modulation of bloodbrain barrier permeability. Cell. Mol. Neurobiol. 20:131-147.
2. Babinska A, et al. 2007. The F11 receptor (F11R/JAM-A) in atherothrombosis: overexpression of F11R in atherosclerotic plaques. Thromb. Haemost. 97:272-281.
3. Bazzoni G. 2011. Pathobiology of junctional adhesion molecules. Antioxid. Redox Signal. 15:1221-1234.
4. Bazzoni G, Dejana E. 2004. Endothelial cell-to-cell junctions: molecular organization and role in vascular homeostasis. Physiol. Rev. 84:869-901.
5. Bazzoni G, et al. 2000. Homophilic interaction of junctional adhesion molecule. J. Biol. Chem. 275:30970-30976.
6. Bruewer M, et al. 2005. Interferon-gamma induces internalization of epithelial tight junction proteins via a macropinocytosis-like process. FASEB J. 19:923-933.
7. Carbajal JM, Schaeffer RC, Jr. 1999. RhoA inactivation enhances endothelial barrier function. Am. J. Physiol. 277:C955-C964.
8. Cohn ZA. 1974. The isolation and cultivation of mononuclear phagocytes. Methods Enzymol. 32:758-765.
9. Corada M, et al. 2005. Junctional adhesion molecule-A-deficient polymorphonuclear cells show reduced diapedesis in peritonitis and heart ischemia-reperfusion injury. Proc. Natl. Acad. Sci. U. S. A. 102:10634-10639.
10. Crane IJ, Liversidge J. 2008. Mechanisms of leukocyte migration across the blood-retina barrier. Semin. Immunopathol. 30:165-177.
11. Del Maschio A, et al. 1999. Leukocyte recruitment in the cerebrospinal fluid of mice with experimental meningitis is inhibited by an antibody to junctional adhesion molecule (JAM). J. Exp. Med. 190:1351-1356.
12. Diacovo TG, Roth SJ, Buccola JM, Bainton DF, Springer TA. 1996. Neutrophil rolling, arrest, and transmigration across activated, surfaceadherent platelets via sequential action of P-selectin and the beta 2-integrin CD11b/CD18. Blood 88:146-157.
13. Fraemohs L, Koenen RR, Ostermann G, Heinemann B, Weber C. 2004. The functional interaction of the beta 2 integrin lymphocyte functionassociated antigen-1 with junctional adhesion molecule-A is mediated by the I domain. J. Immunol. 173:6259-6264.
14. Griffith GR, Consigli RA. 1984. Isolation and characterization of monopinocytotic vesicles containing polyomavirus from the cytoplasm of infected mouse kidney cells. J. Virol. 50:77-85.
15. Itoh M, et al. 2001. Junctional adhesion molecule (JAM) binds to PAR-3: a possible mechanism for the recruitment of PAR-3 to tight junctions. J. Cell Biol. 154:491-497.
16. Kazakoff PW, McGuire TR, Hoie EB, Cano M, Iversen PL. 1995. An in vitro model for endothelial permeability: assessment of monolayer integrity. In Vitro Cell. Dev. Biol. Anim. 31:846-852.
17. Keiper T, Santoso S, Nawroth PP, Orlova V, Chavakis T. 2005. The role of junctional adhesion molecules in cell-cell interactions. Histol. Histopathol. 20:197-203.
18. Kostrewa D, et al. 2001. X-ray structure of junctional adhesion molecule: structural basis for homophilic adhesion via a novel dimerization motif. EMBO J. 20:4391-4398.
19. Lamagna C, et al. 2005. Dual interaction of JAM-C with JAM-B and alpha(M)beta2 integrin: function in junctional complexes and leukocyte adhesion. Mol. Biol. Cell 16:4992-5003.
20. Ley K, Laudanna C, Cybulsky MI, Nourshargh S. 2007. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat. Rev. Immunol. 7:678-689.
21. Lochhead JJ, et al. 2010. Oxidative stress increases blood-brain barrier permeability and induces alterations in occludin during hypoxiareoxygenation. J. Cereb. Blood Flow Metab. 30:1625-1636.
22. Mamdouh Z, Mikhailov A, Muller WA. 2009. Transcellular migration of leukocytes is mediated by the endothelial lateral border recycling compartment. J. Exp. Med. 206:2795-2808.
23. Marchiando AM, et al. 2010. Caveolin-1-dependent occludin endocytosis is required for TNF-induced tight junction regulation in vivo. J. Cell Biol. 189:111-126.
24. Martineau M, Galli T, Baux G, Mothet JP. 2008. Confocal imaging and tracking of the exocytotic routes for D-serine-mediated gliotransmission. Glia 56:1271-1284.
25. Martin-Padura I, et al. 1998. Junctional adhesion molecule, a novel member of the immunoglobulin superfamily that distributes at intercellular junctions and modulates monocyte transmigration. J. Cell Biol. 142: 117-127.
26. Matsuda M, Kubo A, Furuse M, Tsukita S. 2004. A peculiar internalization of claudins, tight junction-specific adhesion molecules, during the intercellular movement of epithelial cells. J. Cell Sci. 117:1247-1257.
27. McCaffrey G, et al. 2007. Tight junctions contain oligomeric protein assembly critical for maintaining blood-brain barrier integrity in vivo. J. Neurochem. 103:2540-2555.
28. Mukherjee K, et al. 2000. Live Salmonella recruits N-ethylmaleimidesensitive fusion protein on phagosomal membrane and promotes fusion with early endosome. J. Cell Biol. 148:741-753.
29. Muller WA. 2003. Leukocyte-endothelial-cell interactions in leukocyte transmigration and the inflammatory response. Trends Immunol. 24: 327-334.
30. Muro S, et al. 2003. A novel endocytic pathway induced by clustering endothelial ICAM-1 or PECAM-1. J. Cell Sci. 116:1599-1609.
31. Nusrat A, et al. 2000. Tight junctions are membrane microdomains. J. Cell Sci. 113(Pt 10):1771-1781.
32. Ostermann G, et al. 2005. Involvement of JAM-A in mononuclear cell recruitment on inflamed or atherosclerotic endothelium: inhibition by soluble JAM-A. Arterioscler. Thromb. Vasc. Biol. 25:729-735.
33. Ostermann G, Weber KS, Zernecke A, Schroder A, Weber C. 2002. JAM-1 is a ligand of the beta(2) integrin LFA-1 involved in transendothelial migration of leukocytes. Nat. Immunol. 3:151-158.
34. Ozaki H, et al. 2000. Junctional adhesion molecule (JAM) is phosphorylated by protein kinase C upon platelet activation. Biochem. Biophys. Res. Commun. 276:873-878.
35. Ozaki H, et al. 1999. Cutting edge: combined treatment of TNF-alpha and IFN-gamma causes redistribution of junctional adhesion molecule in human endothelial cells. J. Immunol. 163:553-557.
36. Persidsky Y, et al. 2006. Rho-mediated regulation of tight junctions during monocyte migration across the blood-brain barrier in HIV-1 encephalitis (HIVE). Blood 107:4770-4780.
37. Petri B, Bixel MG. 2006. Molecular events during leukocyte diapedesis. FEBS J. 273:4399-4407.
38. Ransohoff RM, Liu L, Cardona AE. 2007. Chemokines and chemokine receptors: multipurpose players in neuroinflammation. Int. Rev. Neurobiol. 82:187-204.
39. Roberts TK, Buckner CM, Berman JW. 2010. Leukocyte transmigration across the blood-brain barrier: perspectives on neuroAIDS. Front. Biosci. 15:478-536.
40. Sakakibara T, Nemoto Y, Nukiwa T, Takeshima H. 2004. Identification and characterization of a novel Rho GTPase activating protein implicated in receptor-mediated endocytosis. FEBS Lett. 566:294-300.
41. Shaw SK, et al. 2004. Coordinated redistribution of leukocyte LFA-1 and endothelial cell ICAM-1 accompany neutrophil transmigration. J. Exp. Med. 200:1571-1580.
42. Sobocki T, et al. 2006. Genomic structure, organization and promoter analysis of the human F11R/F11 receptor/junctional adhesion molecule-1/JAM-A. Gene 366:128-144.
43. Spindler V, Schlegel N, Waschke J. 2010. Role of GTPases in control of microvascular permeability. Cardiovasc. Res. 87:243-253.
44. Stamatovic SM, Dimitrijevic OB, Keep RF, Andjelkovic AV. 2006. Protein kinase Calpha-RhoA cross-talk in CCL2-induced alterations in brain endothelial permeability. J. Biol. Chem. 281:8379-8388.
45. Stamatovic SM, Keep RF, Andjelkovic AV. 2011. Tracing the endocytosis of claudin-5 in brain endothelial cells. Methods Mol. Biol. 762:303-320.
46. Stamatovic SM, Keep RF, Kunkel SL, Andjelkovic AV. 2003. Potential role of MCP-1 in endothelial cell tight junction 'opening': signaling via Rho and Rho kinase. J. Cell Sci. 116:4615-4628.
47. Stamatovic SM, Keep RF, Wang MM, Jankovic I, Andjelkovic AV. 2009. Caveolae-mediated internalization of occludin and claudin-5 during CCL2-induced tight junction remodeling in brain endothelial cells. J. Biol. Chem. 284:19053-19066.
48. Stamatovic SM, et al. 2005. Monocyte chemoattractant protein-1 regulation of blood-brain barrier permeability. J. Cereb. Blood Flow Metab. 25:593-606.
49. Tjelle TE, Brech A, Juvet LK, Griffiths G, Berg T. 1996. Isolation and characterization of early endosomes, late endosomes and terminal lysosomes: their role in protein degradation. J. Cell Sci. 109(Pt 12):2905-2914.
50. Turowski P, Adamson P, Greenwood J. 2005. Pharmacological targeting of ICAM-1 signaling in brain endothelial cells: potential for treating neuroinflammation. Cell. Mol. Neurobiol. 25:153-170.
51. Utech M, et al. 2005. Mechanism of IFN-gamma-induced endocytosis of tight junction proteins: myosin II-dependent vacuolarization of the apical plasma membrane. Mol. Biol. Cell 16:5040-5052.
52. Utech M, Mennigen R, Bruewer M. 2010. Endocytosis and recycling of tight junction proteins in inflammation. J. Biomed. Biotechnol. 2010: 484987.
53. Weber C. 2003. Novel mechanistic concepts for the control of leukocyte transmigration: specialization of integrins, chemokines, and junctional molecules. J. Mol. Med. (Berl.) 81:4-19.
54. Weber C, Fraemohs L, Dejana E. 2007. The role of junctional adhesion molecules in vascular inflammation. Nat. Rev. Immunol. 7:467-477.
55. Williams LA, Martin-Padura I, Dejana E, Hogg N, Simmons DL. 1999. Identification and characterisation of human junctional adhesion molecule (JAM). Mol. Immunol. 36:1175-1188.
56. Wojciak-Stothard B, Entwistle A, Garg R, Ridley AJ. 1998. Regulation of TNF-alpha-induced reorganization of the actin cytoskeleton and cell-cell junctions by Rho, Rac, and Cdc42 in human endothelial cells. J. Cell. Physiol. 176:150-165.
57. Wojcikiewicz EP, et al. 2009. LFA-1 binding destabilizes the JAM-A homophilic interaction during leukocyte transmigration. Biophys. J. 96: 285-293.
58. Wyman TH, et al. 2002. A two-insult in vitro model of PMN-mediated pulmonary endothelial damage: requirements for adherence and chemokine release. Am. J. Physiol. Cell Physiol. 283:C1592-C1603.
59. Xu H, Dawson R, Crane IJ, Liversidge J. 2005. Leukocyte diapedesis in vivo induces transient loss of tight junction protein at the blood-retina barrier. Invest. Ophthalmol. Vis. Sci. 46:2487-2494.
60. Yuan Y, Fleming BP. 1990. A method for isolation and fluorescent labeling of rat neutrophils for intravital microvascular studies. Microvasc. Res. 40:218-229.
61. Zinchuk V, Zinchuk O, Okada T. 2007. Quantitative colocalization analysis of multicolor confocal immunofluorescence microscopy images: pushing pixels to explore biological phenomena. Acta Histochem. Cytochem. 40:101-111.